- Home
- PETZ vs CHRO Comparison
PETZ vs CHRO Comparison
Compare PETZ & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- CHRO
- Stock Information
- Founded
- PETZ 2002
- CHRO 2002
- Country
- PETZ China
- CHRO United States
- Employees
- PETZ N/A
- CHRO N/A
- Industry
- PETZ Steel/Iron Ore
- CHRO
- Sector
- PETZ Industrials
- CHRO
- Exchange
- PETZ Nasdaq
- CHRO Nasdaq
- Market Cap
- PETZ 12.9M
- CHRO 10.7M
- IPO Year
- PETZ 2017
- CHRO 2024
- Fundamental
- Price
- PETZ $1.11
- CHRO $1.45
- Analyst Decision
- PETZ
- CHRO Strong Buy
- Analyst Count
- PETZ 0
- CHRO 1
- Target Price
- PETZ N/A
- CHRO N/A
- AVG Volume (30 Days)
- PETZ 8.7K
- CHRO 8.2K
- Earning Date
- PETZ 04-28-2025
- CHRO 03-27-2025
- Dividend Yield
- PETZ N/A
- CHRO N/A
- EPS Growth
- PETZ N/A
- CHRO N/A
- EPS
- PETZ N/A
- CHRO N/A
- Revenue
- PETZ $3,278,453.00
- CHRO N/A
- Revenue This Year
- PETZ N/A
- CHRO N/A
- Revenue Next Year
- PETZ N/A
- CHRO N/A
- P/E Ratio
- PETZ N/A
- CHRO N/A
- Revenue Growth
- PETZ 2.46
- CHRO N/A
- 52 Week Low
- PETZ $1.03
- CHRO $0.45
- 52 Week High
- PETZ $1.74
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- PETZ 32.84
- CHRO 43.38
- Support Level
- PETZ $1.10
- CHRO $1.34
- Resistance Level
- PETZ $1.41
- CHRO $2.00
- Average True Range (ATR)
- PETZ 0.09
- CHRO 0.17
- MACD
- PETZ -0.03
- CHRO -0.02
- Stochastic Oscillator
- PETZ 3.23
- CHRO 16.58
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.